These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30761671)

  • 21. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.
    Colzato LS; Waszak F; Nieuwenhuis S; Posthuma D; Hommel B
    Neuropsychologia; 2010 Jul; 48(9):2764-8. PubMed ID: 20434465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
    Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
    Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of transcranial direct current stimulation (tDCS) on executive functions: influence of COMT Val/Met polymorphism.
    Plewnia C; Zwissler B; Längst I; Maurer B; Giel K; Krüger R
    Cortex; 2013; 49(7):1801-7. PubMed ID: 23237479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients.
    Al-Asmary S; Kadasah S; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2014 Apr; 13(2):3079-88. PubMed ID: 24782165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD.
    Taerk E; Grizenko N; Ben Amor L; Lageix P; Mbekou V; Deguzman R; Torkaman-Zehi A; Ter Stepanian M; Baron C; Joober R
    BMC Med Genet; 2004 Dec; 5():30. PubMed ID: 15613245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between physical activity and BMD in young men is modulated by catechol-O-methyltransferase (COMT) genotype: the GOOD study.
    Lorentzon M; Eriksson AL; Nilsson S; Mellström D; Ohlsson C
    J Bone Miner Res; 2007 Aug; 22(8):1165-72. PubMed ID: 17451372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val(158) Met polymorphism in adults with 22q11 deletion syndrome.
    de Koning MB; Boot E; Bloemen OJ; van Duin ED; Abel KM; de Haan L; Linszen DH; van Amelsvoort TA
    J Psychopharmacol; 2012 Dec; 26(12):1548-60. PubMed ID: 22952320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Gil-Crujera A; Cigarán-Méndez M; Peñacoba-Puente C
    J Pain; 2012 Nov; 13(11):1068-74. PubMed ID: 23025981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report.
    Thaker GK; Wonodi I; Avila MT; Hong LE; Stine OC
    Am J Psychiatry; 2004 Dec; 161(12):2320-2. PubMed ID: 15569909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catechol-O-methyltransferase (COMT) val158met genotype is associated with BOLD response as a function of task characteristic.
    Ettinger U; Kumari V; Collier DA; Powell J; Luzi S; Michel TM; Zedomi O; Williams SC
    Neuropsychopharmacology; 2008 Dec; 33(13):3046-57. PubMed ID: 18235427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The divergent impact of catechol-O-methyltransferase (COMT) Val
    Zhang H; Li J; Yang B; Ji T; Long Z; Xing Q; Shao D; Bai H; Sun J; Cao F
    Compr Psychiatry; 2018 Feb; 81():33-41. PubMed ID: 29222971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
    Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.
    Caldú X; Vendrell P; Bartrés-Faz D; Clemente I; Bargalló N; Jurado MA; Serra-Grabulosa JM; Junqué C
    Neuroimage; 2007 Oct; 37(4):1437-44. PubMed ID: 17689985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between hypnotizability and the catechol-O-methyltransferase (COMT) polymorphism.
    Szekely A; Kovacs-Nagy R; Bányai EI; Gosi-Greguss AC; Varga K; Halmai Z; Ronai Z; Sasvari-Szekely M
    Int J Clin Exp Hypn; 2010 Jul; 58(3):301-15. PubMed ID: 20509070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.